Actively Recruiting
Pilot Trial of the RUBI Program for Autistic Adults
Led by Seattle Children's Hospital · Updated on 2024-09-19
80
Participants Needed
3
Research Sites
17 weeks
Total Duration
On this page
Sponsors
S
Seattle Children's Hospital
Lead Sponsor
E
Els for Autism
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate if a redesigned version of the RUBI parenting intervention can reduce challenging behaviors and improve adaptive skills in autistic adults with co-occurring challenging behaviors. The main questions it aims to answer are: * Is the redesigned RUBI intervention feasible and acceptable for autistic adults and their families? * Does the redesigned RUBI intervention reduce challenging behaviors and enhance the quality of life for autistic adults? * Researchers will compare the redesigned RUBI intervention to an active control group, Introduction to the Science and Lived Experience of Autism (ISLEA), to see if RUBI is more effective in improving outcomes for autistic adults and their families. Participants will: * Attend sessions where they receive either the RUBI intervention or the ISLEA program. * Engage in activities designed to promote communication, co-regulation, and autonomy in the context of supporting autistic adults. * Complete assessments at the start, throughout, and at the end of the 20-week trial to evaluate outcomes such as challenging behaviors, adaptive skills, and quality of life.
CONDITIONS
Official Title
Pilot Trial of the RUBI Program for Autistic Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is an autistic adult aged 18 years or older
- Participant lives at home with their parent and can attend each session
- Participant has a community diagnosis of autism confirmed by records and a Social Communication Questionnaire score over 15
- Participant has mild to moderate challenging behaviors based on a parent-rated Emotion Dysregulation Inventory score above the 50th percentile
- Participant has receptive language skills equivalent to over 18 months on the Mullen Scales of Early Learning or similar measure
- Participant has a stable educational or vocational plan and is either medication free or on stable medication with no changes in the past 6 weeks or planned for the next 16 weeks
- Parent or legally authorized representative can attend each session
You will not qualify if you...
- Participant has serious medical conditions requiring immediate care, such as uncontrolled seizures
- Participant has serious behavioral challenges that pose safety concerns, like self-injurious behaviors or aggression causing tissue damage, requiring more intensive treatment
- Parent or legally authorized representative is unable to attend weekly virtual or in-person sessions over 20 weeks
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Els for Autism Foundation
Jupiter, Florida, United States, 33458
Not Yet Recruiting
2
A.J. Drexel Autism Institute
Philadelphia, Pennsylvania, United States, 19104
Not Yet Recruiting
3
Seattle Children's Autism Center
Seattle, Washington, United States, 98115
Actively Recruiting
Research Team
D
Daina M Tagavi, PhD
CONTACT
C
Catherine Dick, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here